From: Predicting hypoglycemia after treatment of hyperkalemia with insulin and glucose (Glu-K60 score)
Variables | Univariable | Multivariable (Full model) †| Multivariable (Reduced model round #1) ‡ | Multivariable (Reduced model round #2) ∫ | Reduced model round #3 ¶ | Assigned risk item score from reduced model round #2 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Odds ratio (95% CI) | p-value* | AuROC (95% CI) | Odds ratio (95% CI) | p-value* | Odds ratio (95% CI) | p-value* | Odds ratio (95% CI) | p-value* | β | Odds ratio (95% CI) | p-value* |  | |
Age – year | |||||||||||||
 ≤ 60 | Ref |  |  | Ref |  | Ref |  | Ref |  |  |  |  |  |
 > 60 | 1.68 (0.93—3.04) | 0.084 | 0.565 (0.492—0.638) | 1.89 (1.02—3.50) | 0.043 | 1.85 (1.01—3.39) | 0.045 | 1.75 (0.96—3.19) | 0.067 | 0.56 |  |  | 2 |
Female | 0.67 (0.36—1.25) | 0.209 | 0.546 (0.477—0.615) | 0.58 (0.30—1.12) | 0.102 |  |  |  |  |  |  |  |  |
BMI – kg/m2 | |||||||||||||
 < 18.5 | 1.84 (0.92—3.69) | 0.085 | 0.548 (0.486—0.611) | 1.94 (0.93—4.04) | 0.077 |  |  |  |  |  |  |  |  |
 ≥ 18.5 | Ref |  |  | Ref |  |  |  |  |  |  |  |  |  |
Pretreatment blood glucose – mg/dL | |||||||||||||
 ≤ 100 (≤ 5.6 mmol/L) | 2.23 (1.24—4.03) | 0.008 | 0.595 (0.522—0.668) | 2.04 (1.11—3.75) | 0.021 | 2.23 (1.22—4.06) | 0.009 | 2.30 (1.27—4.16) | 0.006 | 0.83 | 2.23 (1.24—4.03) | 0.008 | 3 |
 > 100 (> 5.6 mmol/L) | Ref |  |  | Ref |  | Ref |  | Ref |  |  | Ref |  |  |
Pretreatment serum potassium – mmol/L | |||||||||||||
 ≤ 6 | Ref |  |  | Ref |  | Ref |  |  |  |  |  |  |  |
 > 6 | 1.90 (0.96—3.77) | 0.065 | 0.566 (0.503—0.630) | 2.26 (1.09—4.65) | 0.028 | 1.93 (0.96—3.86) | 0.065 |  |  |  |  |  |  |
Pretreatment serum creatinine – mg/dL | |||||||||||||
 ≤ 3.3 (≤ 291.7 µmol/L) | Ref |  |  | Ref |  |  |  |  |  |  |  |  |  |
 > 3.3 (> 291.7 µmol/L) | 1.11 (0.62—2.00) | 0.725 | 0.513 (0.440—0.586) | 1.06 (0.57—1.96) | 0.855 |  |  |  |  |  |  |  |  |